ArticleNature communications2026

Impact of the anti-inflammatory macrolide glasmacinal on the gut microbiota of healthy adults: an open-label trial.

Tsegaye Sewunet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.